Lin Ni
Private Equity Investor bei 6 Dimensions Capital
Profil
Lin Ni is a professional with experience in the biopharmaceutical industry.
Currently, she is a Managing Director at 6 Dimensions Capital.
Previously, she worked as a Managing Director at Frontline Bioventures.
She also held the position of Director at Shanghai Ark Biopharmaceutical Co., Ltd.
for a brief period in 2021.
In addition, she served as a Non-Executive Director at Genor Biopharma Holdings Ltd.
from 2021 to 2022.
Dr. Ni earned a doctorate degree from Osaka University in 2009.
Aktive Positionen von Lin Ni
| Unternehmen | Position | Beginn |
|---|---|---|
6 Dimensions Capital
 6 Dimensions Capital Investment ManagersFinance 6 Dimensions Capital is an independent private equity firm headquartered in China. The firm was founded in 2017. | Private Equity Investor | 18.05.2017 |
Ehemalige bekannte Positionen von Lin Ni
| Unternehmen | Position | Ende |
|---|---|---|
| GENOR BIOPHARMA HOLDINGS LIMITED | Direktor/Vorstandsmitglied | 29.07.2022 |
| Frontline Bioventures | Direktor/Vorstandsmitglied | 18.05.2017 |
Shanghai Ark Biopharmaceutical Co., Ltd.
 Shanghai Ark Biopharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Shanghai Ark Biopharmaceutical Co., Ltd. engages in biopharmaceutical services. It is a biopharmaceutical company which focuses on the discovery and development of novel therapeutics addressing unmet medical needs in respiratory and lung diseases. The firm’s product portfolio covering full disease cycle and patient segmentations, its drug candidates addresses a spectrum of acute and chronic respiratory and lung diseases. The company was founded by Jim Zhen WU and Wu Zheng Bo in April 2014 and is headquartered in Shanghai, China. | Direktor/Vorstandsmitglied | - |
Ausbildung von Lin Ni
| Osaka University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| GENOR BIOPHARMA HOLDINGS LIMITED | Health Technology |
| Private Unternehmen | 3 |
|---|---|
| Frontline Bioventures | Finance |
6 Dimensions Capital
6 Dimensions Capital Investment ManagersFinance 6 Dimensions Capital is an independent private equity firm headquartered in China. The firm was founded in 2017. | Finance |
Shanghai Ark Biopharmaceutical Co., Ltd.
Shanghai Ark Biopharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Shanghai Ark Biopharmaceutical Co., Ltd. engages in biopharmaceutical services. It is a biopharmaceutical company which focuses on the discovery and development of novel therapeutics addressing unmet medical needs in respiratory and lung diseases. The firm’s product portfolio covering full disease cycle and patient segmentations, its drug candidates addresses a spectrum of acute and chronic respiratory and lung diseases. The company was founded by Jim Zhen WU and Wu Zheng Bo in April 2014 and is headquartered in Shanghai, China. | Health Technology |
